+86-0635-6175299

Company Details

Shandong Haohong Biotechnology Co., Ltd.

[Shandong,China]

Business Type:Manufacturer

Main Markets: Americas , Asia , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide

Exporter:71% - 80%

Certs:Test Report, ISO9001
Language

Shandong Haohong Biotechnology Co., Ltd.

 HomeNewsSupply of high-quality Cabozantinib API and Intermediates

Supply of high-quality Cabozantinib API and Intermediates

2021-07-01

What is Cabozantinib?

Cabozantinib is a new molecular targeted drug developed by exelixis biopharmaceutical company in the United States.Cabozantinib shows dose-dependent inhibition of tumor growth and tumor regression, associated with disruption of the tumor vasculature and extensive tumor cell apoptosis.On November 29, 2012, the US Food and Drug Administration (FDA) approved cabotinib for the treatment of unresectable malignant locally advanced or metastatic medullary thyroid carcinoma.

Shandong Haohong Biotechnology Co., Ltd is mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, tofacitinib citrate, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized.

Cabozantinib API And Intermediates has always been one of the main products promoted by our company.The product purity is at least 99%.We can offer best quality product with perfect service, full documents support, factory audit is availbale.

Our Cabozantinib Intermediate list is as following, we have all the below intermedites offering all year.

cabozantinib

Cabozantinib-1 Cabozantinib-2

If you want to know more information about our company and products, please visit our website at http://www.haohongpharma.com. We will offer the best price and the best quality for you.

Previous: Canadian researchers have developed drugs to treat diabetic retinopathy

Next: Supply of High-quality Bicalutamide Intermediates

 HomeNewsSupply of high-quality Cabozantinib API and Intermediates

Shandong Haohong Biotechnology Co., Ltd.